NRC Health Announces Third Quarter 2026 Results
NRC Health reported Q3 2026 revenue of $38.4 million, up 11% year-over-year, with TRCV of $154.1 million, up 9%. GAAP net income was $4.7 million (12% of revenue) and diluted EPS was $0.21, up from $0.18 a year ago; Adjusted EBITDA was $10.9 million at a 28% margin, down from 31% last year.
Key figures
- Eps
- 0.21
- Revenue
- 38400000
- Revenue Yoy
- 11%
- Fcf
- 6982000
- Trcv
- 154100000
- Trcv yoy
- 9%
- Fcf margin
- 18%
- Net income
- 4700000
- Adjusted ebitda
- 10868000
- Dividend per share
- 0.16
- Operating cash flow
- 8020000
- Adjusted ebitda margin
- 28%
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.